Table of Contents for the Digital Edition of Drug Information Journal - March 2010 Drug Information Journal - March 2010 Table of Contents Orphan Drug Development: Opportunities and Challenges from a Midsized to Large Company Perspective Development of Clinical Trial Agreement Principles The Way Forward in Package Insert User Tests From a CRO’s Perspective Change in Student Perception After a Pharmaceutical Industry Advanced Pharmacy Practice Experience Coping With the Regulatory Realities of Follow-on Biologics and the Nuances of US and European Regulations Determining an Adaptive Exclusion Procedure Following Discovery of an Association Between the Whole Genome and Adverse Drug Reactions Exact Critical Values for Farrington-Manning Noninferiority Exact Test Noninferiority Margin for Clinical Trials of Antibacterial Drugs for Nosocomial Pneumonia E-business in the Regulation of Medicines in Serbia Do Drug Price Adjustment Policies Work? The Impact of Physician Financial Incentive Plans on the Implementation of Drug Cost Containment Mechanisms 2010 EuroMeeting Student Poster Abstracts Drug Information Journal - March 2010 Drug Information Journal - March 2010 - (Page intro) Drug Information Journal - March 2010 - Drug Information Journal - March 2010 (Page Cover1) Drug Information Journal - March 2010 - Drug Information Journal - March 2010 (Page Cover2) Drug Information Journal - March 2010 - Drug Information Journal - March 2010 (Page i) Drug Information Journal - March 2010 - Drug Information Journal - March 2010 (Page ii) Drug Information Journal - March 2010 - Drug Information Journal - March 2010 (Page iii) Drug Information Journal - March 2010 - Drug Information Journal - March 2010 (Page iv) Drug Information Journal - March 2010 - Drug Information Journal - March 2010 (Page vi) Drug Information Journal - March 2010 - Drug Information Journal - March 2010 (Page vii) Drug Information Journal - March 2010 - Table of Contents (Page viii) Drug Information Journal - March 2010 - Table of Contents (Page ix) Drug Information Journal - March 2010 - Orphan Drug Development: Opportunities and Challenges from a Midsized to Large Company Perspective (Page 101) Drug Information Journal - March 2010 - Orphan Drug Development: Opportunities and Challenges from a Midsized to Large Company Perspective (Page 102) Drug Information Journal - March 2010 - Orphan Drug Development: Opportunities and Challenges from a Midsized to Large Company Perspective (Page 103) Drug Information Journal - March 2010 - Orphan Drug Development: Opportunities and Challenges from a Midsized to Large Company Perspective (Page 104) Drug Information Journal - March 2010 - Orphan Drug Development: Opportunities and Challenges from a Midsized to Large Company Perspective (Page 105) Drug Information Journal - March 2010 - Orphan Drug Development: Opportunities and Challenges from a Midsized to Large Company Perspective (Page 106) Drug Information Journal - March 2010 - Orphan Drug Development: Opportunities and Challenges from a Midsized to Large Company Perspective (Page 107) Drug Information Journal - March 2010 - Orphan Drug Development: Opportunities and Challenges from a Midsized to Large Company Perspective (Page 108) Drug Information Journal - March 2010 - Orphan Drug Development: Opportunities and Challenges from a Midsized to Large Company Perspective (Page 109) Drug Information Journal - March 2010 - Orphan Drug Development: Opportunities and Challenges from a Midsized to Large Company Perspective (Page 110) Drug Information Journal - March 2010 - Development of Clinical Trial Agreement Principles (Page 111) Drug Information Journal - March 2010 - Development of Clinical Trial Agreement Principles (Page 112) Drug Information Journal - March 2010 - Development of Clinical Trial Agreement Principles (Page 113) Drug Information Journal - March 2010 - Development of Clinical Trial Agreement Principles (Page 114) Drug Information Journal - March 2010 - Development of Clinical Trial Agreement Principles (Page 115) Drug Information Journal - March 2010 - Development of Clinical Trial Agreement Principles (Page 116) Drug Information Journal - March 2010 - Development of Clinical Trial Agreement Principles (Page 117) Drug Information Journal - March 2010 - Development of Clinical Trial Agreement Principles (Page 118) Drug Information Journal - March 2010 - The Way Forward in Package Insert User Tests From a CRO’s Perspective (Page 119) Drug Information Journal - March 2010 - The Way Forward in Package Insert User Tests From a CRO’s Perspective (Page 120) Drug Information Journal - March 2010 - The Way Forward in Package Insert User Tests From a CRO’s Perspective (Page 121) Drug Information Journal - March 2010 - The Way Forward in Package Insert User Tests From a CRO’s Perspective (Page 122) Drug Information Journal - March 2010 - The Way Forward in Package Insert User Tests From a CRO’s Perspective (Page 123) Drug Information Journal - March 2010 - The Way Forward in Package Insert User Tests From a CRO’s Perspective (Page 124) Drug Information Journal - March 2010 - The Way Forward in Package Insert User Tests From a CRO’s Perspective (Page 125) Drug Information Journal - March 2010 - The Way Forward in Package Insert User Tests From a CRO’s Perspective (Page 126) Drug Information Journal - March 2010 - The Way Forward in Package Insert User Tests From a CRO’s Perspective (Page 127) Drug Information Journal - March 2010 - The Way Forward in Package Insert User Tests From a CRO’s Perspective (Page 128) Drug Information Journal - March 2010 - The Way Forward in Package Insert User Tests From a CRO’s Perspective (Page 129) Drug Information Journal - March 2010 - The Way Forward in Package Insert User Tests From a CRO’s Perspective (Page 130) Drug Information Journal - March 2010 - Change in Student Perception After a Pharmaceutical Industry Advanced Pharmacy Practice Experience (Page 131) Drug Information Journal - March 2010 - Change in Student Perception After a Pharmaceutical Industry Advanced Pharmacy Practice Experience (Page 132) Drug Information Journal - March 2010 - Change in Student Perception After a Pharmaceutical Industry Advanced Pharmacy Practice Experience (Page 133) Drug Information Journal - March 2010 - Change in Student Perception After a Pharmaceutical Industry Advanced Pharmacy Practice Experience (Page 134) Drug Information Journal - March 2010 - Change in Student Perception After a Pharmaceutical Industry Advanced Pharmacy Practice Experience (Page 135) Drug Information Journal - March 2010 - Change in Student Perception After a Pharmaceutical Industry Advanced Pharmacy Practice Experience (Page 136) Drug Information Journal - March 2010 - Coping With the Regulatory Realities of Follow-on Biologics and the Nuances of US and European Regulations (Page 137) Drug Information Journal - March 2010 - Coping With the Regulatory Realities of Follow-on Biologics and the Nuances of US and European Regulations (Page 138) Drug Information Journal - March 2010 - Coping With the Regulatory Realities of Follow-on Biologics and the Nuances of US and European Regulations (Page 139) Drug Information Journal - March 2010 - Coping With the Regulatory Realities of Follow-on Biologics and the Nuances of US and European Regulations (Page 140) Drug Information Journal - March 2010 - Coping With the Regulatory Realities of Follow-on Biologics and the Nuances of US and European Regulations (Page 141) Drug Information Journal - March 2010 - Coping With the Regulatory Realities of Follow-on Biologics and the Nuances of US and European Regulations (Page 142) Drug Information Journal - March 2010 - Coping With the Regulatory Realities of Follow-on Biologics and the Nuances of US and European Regulations (Page 143) Drug Information Journal - March 2010 - Coping With the Regulatory Realities of Follow-on Biologics and the Nuances of US and European Regulations (Page 144) Drug Information Journal - March 2010 - Coping With the Regulatory Realities of Follow-on Biologics and the Nuances of US and European Regulations (Page 145) Drug Information Journal - March 2010 - Coping With the Regulatory Realities of Follow-on Biologics and the Nuances of US and European Regulations (Page 146) Drug Information Journal - March 2010 - Determining an Adaptive Exclusion Procedure Following Discovery of an Association Between the Whole Genome and Adverse Drug Reactions (Page 147) Drug Information Journal - March 2010 - Determining an Adaptive Exclusion Procedure Following Discovery of an Association Between the Whole Genome and Adverse Drug Reactions (Page 148) Drug Information Journal - March 2010 - Determining an Adaptive Exclusion Procedure Following Discovery of an Association Between the Whole Genome and Adverse Drug Reactions (Page 149) Drug Information Journal - March 2010 - Determining an Adaptive Exclusion Procedure Following Discovery of an Association Between the Whole Genome and Adverse Drug Reactions (Page 150) Drug Information Journal - March 2010 - Determining an Adaptive Exclusion Procedure Following Discovery of an Association Between the Whole Genome and Adverse Drug Reactions (Page 151) Drug Information Journal - March 2010 - Determining an Adaptive Exclusion Procedure Following Discovery of an Association Between the Whole Genome and Adverse Drug Reactions (Page 152) Drug Information Journal - March 2010 - Determining an Adaptive Exclusion Procedure Following Discovery of an Association Between the Whole Genome and Adverse Drug Reactions (Page 153) Drug Information Journal - March 2010 - Determining an Adaptive Exclusion Procedure Following Discovery of an Association Between the Whole Genome and Adverse Drug Reactions (Page 154) Drug Information Journal - March 2010 - Determining an Adaptive Exclusion Procedure Following Discovery of an Association Between the Whole Genome and Adverse Drug Reactions (Page 155) Drug Information Journal - March 2010 - Determining an Adaptive Exclusion Procedure Following Discovery of an Association Between the Whole Genome and Adverse Drug Reactions (Page 156) Drug Information Journal - March 2010 - Determining an Adaptive Exclusion Procedure Following Discovery of an Association Between the Whole Genome and Adverse Drug Reactions (Page 157) Drug Information Journal - March 2010 - Determining an Adaptive Exclusion Procedure Following Discovery of an Association Between the Whole Genome and Adverse Drug Reactions (Page 158) Drug Information Journal - March 2010 - Exact Critical Values for Farrington-Manning Noninferiority Exact Test (Page 159) Drug Information Journal - March 2010 - Exact Critical Values for Farrington-Manning Noninferiority Exact Test (Page 160) Drug Information Journal - March 2010 - Exact Critical Values for Farrington-Manning Noninferiority Exact Test (Page 161) Drug Information Journal - March 2010 - Exact Critical Values for Farrington-Manning Noninferiority Exact Test (Page 162) Drug Information Journal - March 2010 - Exact Critical Values for Farrington-Manning Noninferiority Exact Test (Page 163) Drug Information Journal - March 2010 - Exact Critical Values for Farrington-Manning Noninferiority Exact Test (Page 164) Drug Information Journal - March 2010 - Noninferiority Margin for Clinical Trials of Antibacterial Drugs for Nosocomial Pneumonia (Page 165) Drug Information Journal - March 2010 - Noninferiority Margin for Clinical Trials of Antibacterial Drugs for Nosocomial Pneumonia (Page 166) Drug Information Journal - March 2010 - Noninferiority Margin for Clinical Trials of Antibacterial Drugs for Nosocomial Pneumonia (Page 167) Drug Information Journal - March 2010 - Noninferiority Margin for Clinical Trials of Antibacterial Drugs for Nosocomial Pneumonia (Page 168) Drug Information Journal - March 2010 - Noninferiority Margin for Clinical Trials of Antibacterial Drugs for Nosocomial Pneumonia (Page 169) Drug Information Journal - March 2010 - Noninferiority Margin for Clinical Trials of Antibacterial Drugs for Nosocomial Pneumonia (Page 170) Drug Information Journal - March 2010 - Noninferiority Margin for Clinical Trials of Antibacterial Drugs for Nosocomial Pneumonia (Page 171) Drug Information Journal - March 2010 - Noninferiority Margin for Clinical Trials of Antibacterial Drugs for Nosocomial Pneumonia (Page 172) Drug Information Journal - March 2010 - Noninferiority Margin for Clinical Trials of Antibacterial Drugs for Nosocomial Pneumonia (Page 173) Drug Information Journal - March 2010 - Noninferiority Margin for Clinical Trials of Antibacterial Drugs for Nosocomial Pneumonia (Page 174) Drug Information Journal - March 2010 - Noninferiority Margin for Clinical Trials of Antibacterial Drugs for Nosocomial Pneumonia (Page 175) Drug Information Journal - March 2010 - Noninferiority Margin for Clinical Trials of Antibacterial Drugs for Nosocomial Pneumonia (Page 176) Drug Information Journal - March 2010 - E-business in the Regulation of Medicines in Serbia (Page 177) Drug Information Journal - March 2010 - E-business in the Regulation of Medicines in Serbia (Page 178) Drug Information Journal - March 2010 - E-business in the Regulation of Medicines in Serbia (Page 179) Drug Information Journal - March 2010 - E-business in the Regulation of Medicines in Serbia (Page 180) Drug Information Journal - March 2010 - E-business in the Regulation of Medicines in Serbia (Page 181) Drug Information Journal - March 2010 - E-business in the Regulation of Medicines in Serbia (Page 182) Drug Information Journal - March 2010 - E-business in the Regulation of Medicines in Serbia (Page 183) Drug Information Journal - March 2010 - E-business in the Regulation of Medicines in Serbia (Page 184) Drug Information Journal - March 2010 - E-business in the Regulation of Medicines in Serbia (Page 185) Drug Information Journal - March 2010 - E-business in the Regulation of Medicines in Serbia (Page 186) Drug Information Journal - March 2010 - E-business in the Regulation of Medicines in Serbia (Page 187) Drug Information Journal - March 2010 - E-business in the Regulation of Medicines in Serbia (Page 188) Drug Information Journal - March 2010 - Do Drug Price Adjustment Policies Work? The Impact of Physician Financial Incentive Plans on the Implementation of Drug Cost Containment Mechanisms (Page 189) Drug Information Journal - March 2010 - Do Drug Price Adjustment Policies Work? The Impact of Physician Financial Incentive Plans on the Implementation of Drug Cost Containment Mechanisms (Page 190) Drug Information Journal - March 2010 - Do Drug Price Adjustment Policies Work? The Impact of Physician Financial Incentive Plans on the Implementation of Drug Cost Containment Mechanisms (Page 191) Drug Information Journal - March 2010 - Do Drug Price Adjustment Policies Work? The Impact of Physician Financial Incentive Plans on the Implementation of Drug Cost Containment Mechanisms (Page 192) Drug Information Journal - March 2010 - Do Drug Price Adjustment Policies Work? The Impact of Physician Financial Incentive Plans on the Implementation of Drug Cost Containment Mechanisms (Page 193) Drug Information Journal - March 2010 - Do Drug Price Adjustment Policies Work? The Impact of Physician Financial Incentive Plans on the Implementation of Drug Cost Containment Mechanisms (Page 194) Drug Information Journal - March 2010 - Do Drug Price Adjustment Policies Work? The Impact of Physician Financial Incentive Plans on the Implementation of Drug Cost Containment Mechanisms (Page 195) Drug Information Journal - March 2010 - Do Drug Price Adjustment Policies Work? The Impact of Physician Financial Incentive Plans on the Implementation of Drug Cost Containment Mechanisms (Page 196) Drug Information Journal - March 2010 - Do Drug Price Adjustment Policies Work? The Impact of Physician Financial Incentive Plans on the Implementation of Drug Cost Containment Mechanisms (Page 197) Drug Information Journal - March 2010 - Do Drug Price Adjustment Policies Work? The Impact of Physician Financial Incentive Plans on the Implementation of Drug Cost Containment Mechanisms (Page 198) Drug Information Journal - March 2010 - 2010 EuroMeeting Student Poster Abstracts (Page 199) Drug Information Journal - March 2010 - 2010 EuroMeeting Student Poster Abstracts (Page 200) Drug Information Journal - March 2010 - 2010 EuroMeeting Student Poster Abstracts (Page 201) Drug Information Journal - March 2010 - 2010 EuroMeeting Student Poster Abstracts (Page 202) Drug Information Journal - March 2010 - 2010 EuroMeeting Student Poster Abstracts (Page 203) Drug Information Journal - March 2010 - 2010 EuroMeeting Student Poster Abstracts (Page 204) Drug Information Journal - March 2010 - 2010 EuroMeeting Student Poster Abstracts (Page Cover3) Drug Information Journal - March 2010 - 2010 EuroMeeting Student Poster Abstracts (Page Cover4) http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1110 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0910 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0710 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0510 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0310 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0110 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1109 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0909 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0709 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0509 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0309 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0109 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1108 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0908 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0708 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0508 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0308 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0108 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1107 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0907 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0707 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0507 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0307 http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.